Incanthera (AQSE:INC) YoY EBITDA Growth : -60.00% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Incanthera's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was -60.00%.

Incanthera's EBITDA per Share for the six months ended in Sep. 2023 was £-0.01.

Incanthera YoY EBITDA Growth Historical Data

The historical data trend for Incanthera's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera YoY EBITDA Growth Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

36.36

7.14

7.69

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial			-	12.50	16.67	14.29	-60.00

Incanthera YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Incanthera's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(-0.012	-	-0.013)	/	\| -0.013 \|
=	7.69 %

Incanthera's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(-0.008	-	-0.005)	/	\| -0.005 \|
=	-60.00 %

Incanthera YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Incanthera's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines